Regeneron Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to
Medically reviewed by Lindsay Slowiczek, PharmD on April 5, 2019. Written by Victor Nguyen, PharmD, MS. Republished with permission from Healthline.
Medically reviewed by Lindsay Slowiczek, PharmD. 1/19. Republished with permission from Healthline. In a special partnership, dLife is proud to
Medically reviewed by Lindsay Slowiczek, PharmD. 11/18. Republished with permission from Healthline. In a special partnership, dLife is proud to
Researchers have demonstrated that the recently developed antidiabetic drug empagliflozin can treat and reverse the progression of heart failure in
Cigna and Express Scripts announced today the launch of a new program which will ensure eligible people with diabetes in participating plans pay no
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: